Search Products | My Account | Shopping Cart   
   You are here: Home > Product > Halo >

OmicsLink™ ORF Expression Clones with HaloTag®

Applications:

Protein Localization:

Using either membrane permeable (TMR, diAcFAM, Coumarin and Oregon Green) or impermeant (Alexa Fluor 488) HaloTag® ligands, one can label intracellular and membrane proteins, respectively. Subsequently, the labeled proteins can be visualized with a fluorescent microscope (Fig. 3). Cell-impermeant fluorescent dyes are particularly useful in studies of plasma membrane protein characteristics when the HaloTag® fusion protein is engineered to be expressed on cellular membrane.


Fig. 3. Live cells expressing HaloTag® fusion protein labeled with three different ligands. HeLa cells transiently transfected with HaloTag® pHT2 expression clones were labeled with 5μM HaloTag® TMR Ligand (Panel A); 10μM HaloTag® diAcFAM Ligand (Panel B); or 25μM HaloTag® Coumarin Ligand (Panel C)

Protein Co-Localization:

If HaloTag®-fusion protein expressing cells are fixed after ligand is added, the labeled cells can be further processed with an antibody against another protein in an immunocytochemistry (IC) assay to determine protein co-localization (Fig. 4). Anti-HaloTag® polyclonal antibody can also be used together with another antibody for co-localization study.


Fig. 4. Fixed cells expressing p65-HaloTag® fusion protein labeled with HaloTag® TMR Ligand and an antibody to tubulin. HeLa cells transiently transfected with the p65-HaloTag® were stained with TMR Ligand for 15 minutes at 37°C. Cells were then fixed and exposed to mouse Anti-βIII tubulin antibody at 1µg/ml followed by incubation with Alexa Fluor™488-conjugated secondary. Panel A: TMR fluorescence. Panel B. Alexa Fluor™-488 fluorescence. Panel C: Overlaid Alexa Fluor ™ -488 and TMR fluorescence and transmitted light. Panel D: Overlaid AlexaFluor™-488 and TMR fluorescence. Please refer to Promega’s manual TM260 for this application

Protein-DNA interaction:

Immobilized ligands (such as HaloLink™ Resin) can be used to precipitate HaloTag® fusion proteins cross-linked to DNA. This protocol abolishes the need for antibodies in classic chromatin immunoprecipitation (ChIP) assays and enables experiments in the absence of highly functional antibodies. Please refer to Promega’s manual #TM075 for this application.

Multiplex pulse-chase labeling for protein trafficking studies:

Using different fluorescent ligands, users can label HaloTag® fusion protein of interest at different time intervals in live cells so that protein trafficking can be monitored over time (Fig. 5). Please refer to Promega’s manual TM260 for this application.


Fig. 5. Spatial and temporal separation of proteins using HaloTag® technology. Twelve hours after cell labeling, imaging showed the differentially labeled proteins as they moved from the cytoplasm to the membrane and as they internalized from the membrane. Detailed description of the experimental design and results can be found in Svendsen, S., et al., (Promega Notes 95 (2007) 16–19).

Protein enrichment, SDS-PAGE and Western blot analysis:

Using biotinylated ligand with immobilized Strepavidin, users can enrich HaloTag® fusion proteins of interest for subsequent protein purification, enzymatic study, mass spectrometry analysis, or post-translational modification. Furthermore, after labeling with fluorescent ligand, HaloTag fusion proteins can be separated by SDS-PAGE, fluoroimaged directly, and/or transferred for Western blot analysis (Fig. 6).


Fig. 6. Fast, efficient and highly specific labeling of the HaloTag® Proteins expressed in mammalian cells. CHO-K1 control cells (lanes 1–6) or cells transiently transfected with HaloTag® pHT2 expression clone (lanes 7–12) were labeled with 5µM HaloTag® TMR Ligand for different periods of time at 37°C (0.5, 1, 2, 5, 15 and 30 minutes). Proteins were resolved by SDS-PAGE and analyzed on a Hitachi FMBIO® fluorescence scanner.

ORF Expression Clones are also available in more than 80 other expression vector systems with different promoters and various N- or C-terminal tags: SNAP, His, GST, MBP, GFP, YFP, AviTag™, HA, Flag, SUMO, IRES and more.

This product is manufactured under licensing agreement with Promega Corporation.
HaloTag® is a trademark of Promega Corporation.
All figures in this page are adapted from Promega with its permission.

HaloTag® Ligands
For research use only. Researchers may use this product in their own research and may modify or link Promega HaloTag® ligands to Promega or customer-supplied moieties. No other use or transfer of this product is authorized without the express, written consent of Promega including, without limitation, Commercial Use. Commercial Use means any and all uses of this product and derivatives by a party for monetary or other consideration and may include but is not limited to use in: (1) product manufacture; and (2) to provide a service, information or data; and/or resale of the product or its derivatives, whether or not such product or derivatives are resold for use in research. With respect to such Commercial Use, or any diagnostic, therapeutic or prophylactic uses, please contact Promega for supply and licensing information. If the purchaser is not willing to accept the conditions of this limited use statement, Promega is willing to accept return of the unopened product and provide purchaser with a full refund. However, in the event that the product is opened, then purchaser agrees to be bound by the conditions of this limited use statement.

HaloTag® Vectors
For research use only. Researchers may use this product in their own research and they may transfer derivatives to others for research use provided that at the time of transfer a copy of this label license is given to the recipients and recipients agree to be bound by the terms of this label license. Researchers shall have no right to modify or otherwise create variations of the nucleotide sequence of the HaloTag® gene. Researchers may however clone heterologous DNA sequences at either or both ends of said HaloTag® gene so as to create fused gene sequences provided that the coding sequence of the resulting HaloTag® gene has no more than four (4) deoxynucleotides missing at the affected terminus when compared to the intact HaloTag® gene sequence. In addition, researchers must do one of the following: (1) use Promega HaloTag® ligands, which can be modified or linked to Promega or customer-supplied moieties, or (2) contact Promega to obtain a license. No other use or transfer of this product or its derivatives is authorized without the express, written consent of Promega including, without limitation, Commercial Use. Commercial Use means any and all uses of this product and derivatives by a party for monetary or other consideration and may include but is not limited to use in: (1) product manufacture; and (2) to provide a service, information or data; and/or resale of the product or its derivatives, whether or not such product or derivatives are resold for use in research. With respect to such Commercial Use, or any diagnostic, therapeutic or prophylactic uses, please contact Promega for supply and licensing information. If the purchaser is not willing to accept the conditions of this limited use statement, Promega is willing to accept return of the unopened product and provide purchaser with a full refund. However, in the event that the product is opened, then purchaser agrees to be bound by the conditions of this limited use statement.


   Copyright© 2001-2008 GeneCopoeia, Inc. All Rights Reserved. Contact us | License | Privacy